<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>immunotherapy enhancement &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/immunotherapy-enhancement/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 25 Nov 2025 23:02:27 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>immunotherapy enhancement &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>CD24a Knockout Boosts Anti-Tumor Immune Response</title>
		<link>https://bioengineer.org/cd24a-knockout-boosts-anti-tumor-immune-response/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 25 Nov 2025 23:02:19 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[anti-tumor immune response]]></category>
		<category><![CDATA[CD24a knockout]]></category>
		<category><![CDATA[immunotherapy enhancement]]></category>
		<category><![CDATA[triple-negative breast cancer]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cd24a-knockout-boosts-anti-tumor-immune-response/</guid>

					<description><![CDATA[In a groundbreaking study that sheds light on the complex interplay between the immune system and tumor microenvironments, researchers have unveiled the significant role of CD24a in modulating immune responses against tumors, particularly in the context of triple-negative breast cancer (TNBC). This research, articulated by Chan et al., published in the Journal of Biomedical Science, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">301285</post-id>	</item>
	</channel>
</rss>
